We are live on ! Find out more
OAM

Oberweis Asset Management Portfolio holdings

AUM $3.39B
1-Year Est. Return 105.5%
This Fund
S&P 500
This Quarter Est. Return
+8.75%
1 Year Est. Return
+105.5%
3 Year Est. Return
+311.52%
5 Year Est. Return
+632.9%
10 Year Est. Return
+11,604.3%
AUM
$550M
AUM Growth
+$52.4M
Cap. Flow
+$19.4M
Cap. Flow %
3.53%
Top 10 Hldgs %
52.39%
Holding
230
New
29
Increased
85
Reduced
59
Closed
34

Top Buys

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$47.5M
2
QURE icon
uniQure
QURE
+$28.2M
3
CACI icon
CACI
CACI
+$6.46M
4
IPHI
INPHI CORPORATION
IPHI
+$4.67M
5
ALTR
Altair Engineering Inc
ALTR
+$4.62M

Top Sells

Rank Stock Value
1
MLNX
Mellanox Technologies, Ltd.
MLNX
+$33.8M
2
GOOS
Canada Goose Holdings
GOOS
+$13.2M
3
BEAT
BioTelemetry, Inc.
BEAT
+$8.78M
4
CYBR
CyberArk
CYBR
+$5.02M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$4.83M

Sector Composition

Rank Sector Weight
1 Healthcare 39.64%
2 Consumer Staples 13.57%
3 Technology 13.22%
4 Industrials 12.46%
5 Consumer Discretionary 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PXLW icon
151
Pixelworks
PXLW
$38.2M
$467K 0.08%
13,196
-5,567
-30% -$239K
DCO icon
152
Ducommun
DCO
$2.7B
$457K 0.08%
10,150
-4,000
-28% -$179K
CONE
153
DELISTED
CyrusOne Inc Common Stock
CONE
$456K 0.08%
7,900
+2,000
+34% +$117K
POLY
154
DELISTED
Plantronics, Inc.
POLY
$452K 0.08%
12,200
+1,000
+9% +$46.4K
ACNT icon
155
Ascent Industries
ACNT
$140M
$449K 0.08%
28,754
-6,246
-18% -$108K
LGND icon
156
Ligand Pharmaceuticals
LGND
$5.76B
$427K 0.08%
5,995
-65,577
-92% -$4.83M
XHR
157
Xenia Hotels & Resorts
XHR
$1.9B
$427K 0.08%
20,460
-1,300
-6% -$28.1K
TRV icon
158
Travelers Companies
TRV
$78.1B
$424K 0.08%
2,834
-47
-2% -$6.78K
JNJ icon
159
Johnson & Johnson
JNJ
$618B
$382K 0.07%
2,743
+4
+0.1% +$554
NEO icon
160
NeoGenomics
NEO
$1.96B
$380K 0.07%
17,300
-23,300
-57% -$511K
ZVO
161
DELISTED
Zovio Inc. Common Stock
ZVO
$378K 0.07%
105,721
-3,350
-3% -$16.7K
INTC icon
162
Intel
INTC
$455B
$377K 0.07%
7,873
+3
+0% +$149
CSBR icon
163
Champions Oncology
CSBR
$74.5M
$376K 0.07%
48,033
– –
CARS icon
164
Cars.com
CARS
$662M
$355K 0.06%
18,000
+6,700
+59% +$143K
MCHX icon
165
Marchex
MCHX
$76.2M
$353K 0.06%
+75,000
New +$359K
BIG
166
DELISTED
Big Lots, Inc.
BIG
$349K 0.06%
12,200
+3,400
+39% +$114K
ATSG
167
DELISTED
Air Transport Services Group
ATSG
$342K 0.06%
14,030
+2,530
+22% +$58.1K
SAVE
168
DELISTED
Spirit Airlines, Inc.
SAVE
$329K 0.06%
6,900
+300
+5% +$15.3K
BDC icon
169
Belden
BDC
$4.83B
$328K 0.06%
5,500
+200
+4% +$11.5K
NX icon
170
Quanex
NX
$819M
$312K 0.06%
16,500
+400
+2% +$6.71K
AMGN icon
171
Amgen
AMGN
$208B
$292K 0.05%
1,582
+1
+0.1% +$179
WOR icon
172
Worthington Enterprises
WOR
$2.77B
$291K 0.05%
11,743
-2,595
-18% -$60.9K
FFIC
173
DELISTED
Flushing Financial
FFIC
$289K 0.05%
13,000
– –
WMT icon
174
Walmart Inc
WMT
$885B
$281K 0.05%
7,629
+12
+0.2% +$414
CLF icon
175
Cleveland-Cliffs
CLF
$6.57B
$275K 0.05%
+25,800
New +$254K
5 6
7
8 9

Similar funds

BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

Oberweis Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Oberweis Asset Management held 230 positions worth $550M, up 11% from $498M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Oberweis Asset Management deployed $19.4M of net new capital in Q2 2019, opening 29 new positions and adding to 85 existing holdings. Its largest new stake was uniQure: 442,900 shares worth $34.6M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 28% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was Ligand Pharmaceuticals, an estimated $4.83M trimmed.

  • Oberweis Asset Management's largest Q2 2019 buy was uniQure: 442,900 shares worth $34.6M.
  • Oberweis Asset Management added most to GW Pharmaceuticals Plc American Depositary Shares in Q2 2019, an estimated $47.5M increase.
  • Oberweis Asset Management's biggest Q2 2019 reduction was Ligand Pharmaceuticals, cutting an estimated $4.83M.
  • Oberweis Asset Management fully exited Mellanox Technologies, Ltd. in Q2 2019, selling an estimated $33.8M.
  • Oberweis Asset Management's ten largest holdings make up 52% of its $550M portfolio in Q2 2019.
  • Oberweis Asset Management opened 29 new positions and closed 34 in Q2 2019.
  • Oberweis Asset Management's portfolio value rose 11% quarter-over-quarter to $550M.

Based on Oberweis Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.